ReviewACS omega2026
Research Progress on ROS Scavenging and Responsive Materials for Biomedical Applications.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive oxygen species (ROS) participate in essential physiological processes such as cellular signaling under normal conditions; however, their excessive accumulation under oxidative stress can induce various diseases. Addressing this challenge, the development of biomaterials capable of precisely regulating ROS levels is of great significance. This review systematically summarizes two classes of biomaterials for modulating oxidative stressROS-scavenging materials and ROS-responsive materialsfrom the perspective of material design principles, elucidating their underlying mechanisms and construction strategies, respectively. ROS-scavenging materials primarily include nanozymes, inorganic nanoparticles, natural antioxidants, and polymers rich in reactive functional groups, which exert antioxidant effects through sustained consumption of excess ROS. In contrast, ROS-responsive materials exploit responsive moieties such as phenylboronic esters, thioketals and diselenides to trigger structural disassembly or drug release within high-ROS microenvironments, thereby enabling spatiotemporally controlled on-demand delivery. Furthermore, this review also discusses the synergistic therapeutic potential of multiresponsive materials. Finally, the major challenges currently facing this field are summarized, and future directions for clinical translation are prospected.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.